As ATRI’s Director of Neuropsychology, Dr. Cecily Jenkins is making important progress toward earlier identification and intervention for Alzheimer’s Disease. In this episode, Dr. Jenkins joins the podcast to explain what neuropsychology is and why it’s such an essential part of ATRI’s work. She also shares an inside look at the work her team is doing to standardize clinical trials across many locations and researchers, and she discusses some important innovations and discoveries that have shifted our approach to Alzheimer's research over the past few decades.
Episode Recap:
- In this episode, we’re talking with Dr. Cecily Jenkins, director of neuropsychology at ATRI (0:41)
- What is neuropsychology, and how did you get interested in it? (2:23)
- How has the field of neuropsychology evolved in recent years? (6:26)
- What do you wish people knew about the research process? (10:54)
- What changes are you and your team making to the research process? (12:42)
- Why is biomarker evidence the most important development of the last 10 years? (19:10)
- What are you most proud of from your time at ATRI? (22:02)
- What is your hope for the future of Alzheimer’s research? (24:44)
- Why is data standardization so important, and what are you doing to support it? (27:56)
- How can people get involved? (33:15)
Learn more about ATRI
Learn about the APT Webstudy
